Business

Celsius Holdings, Inc. Reports Record First Quarter 2022 Financial Results

Revenue of $133.4 million, up 167% from $50.0 million in Q1 2021 Domestic revenue increased 217% to $123.5 million, up from $39.0 million in Q1 2021

articleCelsius Holdings, Inc.May 10, 20224/company/celsius-holdings-inc/news/celsius-holdings-inc-reports-record-first-quarter-2022-financial-results-2022-05-10
Celsius Holdings, Inc. Reports Record First Quarter 2022 Financial Results

About this update from Celsius Holdings, Inc.

[{"type":"text","content":"Revenue of $133.4 million, up 167% from $50.0 million in Q1 2021\nDomestic revenue increased 217% to $123.5 million, up from $39.0 million in Q1 2021\nInternational revenue decreased 10% to $9.9 million, from $11.0 million in Q1 2021\nBOCA RATON, Fla., May 10, 2022 /PRNewswire/ -- Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today reported preliminary financial results for the first quarter ended March 31, 2022. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss the results with the investment community.\n\n \n \n \n \n \n \n\n \nA PDF containing our first quarter 2022 results and full financial tables is available at:https://www.celsiusholdingsinc.com/Q1_2022/\nTo participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:\nUS: 877-709-8150International: 201-689-8354\nWebcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=tSbZnnGx\nAn audio replay of the call will be available on the Company's website at:https://www.celsiusholdingsinc.com/press-releases/\nAbout Celsius Holdings, Inc.Celsius Holdings, Inc. (Nasdaq: CELH), is a global consumer packaged goods company with a proprietary, clinically proven formula for its master brand CELSIUS®. A lifestyle energy drink born in fitness and a pioneer in the rapidly growing energy category. CELSIUS® offers proprietary, functional, essential energy formulas clinically-proven to offer significant health benefits to its users. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. For more information, please visit: http://www.celsiusholdingsinc.com\nForward-Looking StatementsThis press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases, you can identify these statements by forward-looking words such as \"anticipate,\" \"believe,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"should,\" \"will,\" \"would,\" or similar...

More updates from Celsius Holdings, Inc.